The European Commission has unveiled a new health policy package to strengthen innovation, competitiveness, and resilience across the EU health sector. The initiative focuses on biotechnology, medical devices, and cardiovascular disease prevention, aiming to accelerate access to medical innovation for all EU citizens.
Key Points:
- European Biotech Act
- Addresses funding gaps and regulatory bottlenecks.
- Accelerates clinical trials and supports bio-manufacturing.
- Fast-tracks AI-enabled therapies via regulatory sandboxes.
- Safe Hearts Plan
- EU’s first coordinated strategy against cardiovascular disease, the leading cause of premature death.
- Promotes early detection, personalized prevention, and AI-driven data use to reduce health inequalities.
- Medical Device Reforms
- Simplifies approval procedures and digitalizes processes.
- Maintains patient safety and ensures consistent rules for AI-enabled devices.
The measures aim to modernize Europe’s health ecosystem, support domestic innovation, and reinforce the EU’s strategic autonomy in healthcare. The proposals will now move to the European Parliament and the Council for consideration.
By